Phase I-II trial evaluating combined intensity-modulated radiotherapy and in situ gene therapy with or without hormonal therapy in treatment of prostate cancer-interim report on PSA response and biopsy data.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples